Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 156, 243-253
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid DependenceArchives of General Psychiatry, 2011
- A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceDrug and Alcohol Dependence, 2011
- The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain ControlNeuropsychopharmacology, 2011
- μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate InternalizationMolecular Pharmacology, 2010
- Measurement of self-reported HIV risk behaviors in injection drug users: Comparison of standard versus timeline follow-back administration proceduresJournal of Substance Abuse Treatment, 2010
- Buprenorphine tapering schedule and illicit opioid useAddiction, 2009
- Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted YouthJAMA, 2008
- Time‐limited buprenorphine replacement therapy for opioid dependence: 2‐year follow‐up outcomes in relation to programme completion and current agonist therapy statusDrug and Alcohol Review, 2007
- The CES-D ScaleApplied Psychological Measurement, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958